14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Feb 20, 2019 $10.70 $11.25 $10.70 $11.24 640 050
Feb 19, 2019 $10.69 $10.78 $10.23 $10.68 594 624
Feb 15, 2019 $10.00 $10.59 $9.92 $10.53 632 093
Feb 14, 2019 $9.28 $9.98 $9.16 $9.92 516 575
Feb 13, 2019 $9.14 $9.69 $9.10 $9.31 445 414
Feb 12, 2019 $9.04 $9.25 $9.00 $9.08 473 756
Feb 11, 2019 $9.06 $9.12 $8.79 $8.99 379 776
Feb 08, 2019 $8.95 $9.12 $8.90 $8.97 283 909
Feb 07, 2019 $9.00 $9.14 $8.79 $8.96 412 235
Feb 06, 2019 $9.35 $9.35 $8.85 $9.03 355 699
Feb 05, 2019 $8.92 $9.37 $8.92 $9.30 803 334
Feb 04, 2019 $9.06 $9.22 $8.60 $8.87 833 396
Feb 01, 2019 $8.99 $9.22 $8.72 $9.08 342 892
Jan 31, 2019 $8.91 $9.09 $8.80 $9.00 530 530
Jan 30, 2019 $8.45 $9.02 $8.37 $8.89 443 597
Jan 29, 2019 $8.55 $8.87 $8.25 $8.41 399 655
Jan 28, 2019 $8.65 $8.65 $8.26 $8.53 274 239
Jan 25, 2019 $8.73 $8.79 $8.27 $8.78 408 696
Jan 24, 2019 $8.59 $8.80 $8.34 $8.66 369 436
Jan 23, 2019 $8.71 $8.89 $8.48 $8.61 270 611
Jan 22, 2019 $8.92 $8.93 $8.54 $8.67 271 291
Jan 18, 2019 $8.94 $9.12 $8.74 $9.02 324 226
Jan 17, 2019 $8.56 $8.99 $8.44 $8.93 548 384
Jan 16, 2019 $8.74 $8.89 $8.55 $8.59 418 199
Jan 15, 2019 $8.81 $8.95 $8.53 $8.72 395 151
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT